Yüklüyor......
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
OBJECTIVE: To investigate the efficacy and safety of the interleukin-6 receptor antibody tocilizumab in patients with Takayasu arteritis (TAK). METHODS: Patients with TAK who had relapsed within the previous 12 weeks were induced into remission with oral glucocorticoid therapy. In this double-blind,...
Kaydedildi:
| Yayımlandı: | Ann Rheum Dis |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867398/ https://ncbi.nlm.nih.gov/pubmed/29191819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2017-211878 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|